Pharma Articles
Articles are written by renowned pharmaceutical company executives and other professionals from across the world on important topics relating to the business. The part of articles on the pharmaceutical industry focuses on current and developing concerns in fields such as pharmaceutical R&D, drug discovery, clinical trials, pharmaceutical production, biopharmaceuticals, and information technology.
European Pharmaceutical Legal Frameworks: Compliance, Legislation and Regulatory Obligations
If youve ever opened the EUs pharmaceutical rulebook and felt your eyes glaze over youre not alone Directives regulations guidelines delegated acts it can feel like reading a legal maze with no exit sign
Oligonucleotide Manufacturing: Scaling the Next Generation of Medicines
For most of their history oligonucleotides were manufactured the way specialty chemicals are made small batches high cost per gram and patient populations small enough that supply was rarely the limiting factor
Blockchain in Pharma: Strengthening Drug Traceability, Compliance, and Supply Chain Security
For most of the last decade the European pharmaceutical industry framed supply chain integrity as a packaging problem Put a unique identifier on every pack seal it with an antitampering device check it at the point of dispensing and the falsified medicine threat would be contained Since February th...
How M&A Is Reshaping Europe’s Pharmaceutical Pipeline
For most of the past halfcentury a European drugmakers future was written in its own laboratories That model has not disappeared but it has been joined and in many boardrooms overtaken by a second engine of growth the acquisition of externally discovered science
Bridging the Biotech–Pharma Innovation Gap Through Strategic Partnerships
Europe has never lacked ideas Its universities translational institutes and spinout companies consistently generate novel biology from geneediting tools to antibody engineering and mRNA platforms What the continent has struggled with is the journey that follows turning a validated mechanism into an...
COA and Lot Traceability: The Backbone of Reproducible Pharma Research
A pharmaceutical experiment can be repeated with the same protocol instrument settings and analyst yet still produce a different result The obvious suspects are usually the method or the equipment Sometimes the less visible variable is the material itself
Measuring Digital Channels’ ROI in Pharma Marketing
Marketing in pharma is no longer just confined to the facetoface interactions Healthcare Practitioners HCPs have with the sales representatives Digital channels have also been entering this ecosystem with COVID accelerating the adoption What started out as an additional channel is now being viewed a...
The Growing Role of Real-World Evidence in European Drug Development
For decades the randomised controlled trial has been the gold standard of pharmaceutical evidence in Europe and it still is Yet the evidence that shapes a medicines journey from laboratory to patient is no longer confined to the controlled world of the trial protocol Electronic health records diseas...
Strategic Partnerships and Collaborations in the European Pharmaceutical Industry
Pharma strategic partnerships are formal agreements in which two or more companies share resources risk and rewards to develop or commercialize medicines In Europe the main models are licensing codevelopment cocommercialization joint ventures and publicprivate consortia Companies choose based on how...
Strengthening Clinical Trials Through Digital and Decentralized Technologies
For most of the past halfcentury the clinical trial has been organised around the investigator site Participants travelled to hospitals data were recorded at the clinic and monitors travelled again to verify them That model produced the evidence behind modern medicine but it asks a great deal of the...
